Five major pharma stories in one day — Novo's rebrand and AI bets, Bayer's 30-year CKD first, GSK's T-cell engager, and Sanofi's portfolio exit.
|Articles|January 1, 2011
- Pharmaceutical Executive-01-01-2011
- Volume 0
- Issue 0
The List: 2011
Author(s)Walter Armstrong
It's a new year. Even pharma, with its glacial timelines, has its "Out with the old, in with the new" moment. Welcome to 2011!
Advertisement
It's a new year. Even pharma, with its glacial timelines, has its "Out with the old, in with the new" moment. Welcome 2011!
Getty Images / Anna Williams
Articles in this issue
over 15 years ago
Malta: A healthy location for the pharmaceutical industryover 15 years ago
Politics & PDUFAover 15 years ago
The Right Mix for 2011over 15 years ago
The Night Stalkersover 15 years ago
Malta: A Healthy Location for the Pharma IndustryAdvertisement
Related to this article
How the shifting tides in information consumption are resetting expectations for pharma in providing and delivering health education.
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: Lisata Therapeutics Acquires Marea Therapeutics, mAbxience Enters Collaboration with Sandoz
2
Pharmaceutical Executive Daily: FDA Approves Fayuvi
3
The Battle to Own the GLP-1 Patient Journey
4
FDA Approves Fayuvi for Pediatric Patients with Sanfilippo Syndrome Type A
5